FDA devotes new resources to upgrading generic drug safety: but in some instances, the industry is pushing back.

The Food and Drug Administration, concerned about the quality of the generic drugs that represent 84 percent of U.S. prescriptions, is looking more closely at foreign manufacturing plants and weighing other changes in the generic approval process.